Skip to content

Efficacy of New Strategies for Upper Gastrointestinal Cancer Screening in China: An Extended Multicenter Randomized Controlled Trial

Efficacy of New Strategies for Upper Gastrointestinal Cancer Screening in China: An Extended Multicenter Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019203
Enrollment
Unknown
Registered
2018-10-31
Start date
2018-12-15
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper gastrointestinal cancer

Interventions

1:Endoscopic screening in high-risk areas
2:Risk assessment + Endoscopic screening, in high-risk areas
3:Risk assessment + Endoscopic screening, in non-high risk areas
4:Risk assessment + biomarker testing+ Endoscopic screening, in non-high-risk areas

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 69 Years

Inclusion criteria

Inclusion criteria: The local resident aged 40-69 years, no previous cancer history, in a good general condition. No endoscopic screening experience within 3 years, willing to participate.

Exclusion criteria

Exclusion criteria: Individuals who are diagnosed with esophageal cancer, stomach cancer, any other cancer(s), or with any serious diseases, individuals who could not take care of himself or herself, and individuals who were unwilling to receive follow-up examination.

Design outcomes

Primary

MeasureTime frame
Number of screened participants in the covered areas;Detection rate;Eearly diagnosis rate;

Countries

China

Contacts

Public ContactWan-Qing Chen

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences

chenwq@cicams.ac.cn+86 010 87787039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026